Immutable evidence record · ticker
Alnylam Pharmaceuticals, Inc. (A1LN34)
Published as observed on 21 August 2026 at 05:33 BST.
Alnylam Pharmaceuticals, Inc. has a negative company news read. Its latest completed weekly trend is negative.
- As of
- 21 Aug 2026, 05:33
- Scope
- company and instrument
- Evidence
- 21 items
- Independent sources
- 3
- Country
- Brazil
- Sector
- Healthcare
- Previous read
- 44.000
- Change
- 1.000
Verification
Evidence & related research
Company chart →Technicals & Market Dynamics →Technical Research Pack →Company news sentiment →Current financial news →
This is dated market research. Coverage may be delayed, incomplete or unavailable.
Cite this record:
Sharemaestro, Alnylam Pharmaceuticals, Inc. (A1LN34), 2026-08-21, https://sharemaestro.com/evidence/15edd0eb-859d-4121-85f5-8eddeabdf3b6/
Record checksum bc35a60e12db975597954a2e4d5e0f607006e44fb971c03b0193705db60b0fa6
